Radia Johnson, PhD
Senior Director, Computational Discovery Science Tempus AI
Radia Johnson is Senior Director of Computational Discovery Science at Tempus AI, where she leads the application of artificial intelligence, computational biology, and multimodal data analytics to accelerate drug discovery and precision oncology. With more than a decade of experience across biotech and biopharma, including leadership roles at Genentech, Roche, and Gilead Sciences, she has focused on translating large-scale clinical, genomic, and real-world data into actionable insights for target discovery, biomarker development, and patient stratification. Dr. Johnson is a recognized leader in computational oncology, author of numerous peer-reviewed publications, and an advocate for leveraging AI to improve therapeutic development and patient outcomes.
Seminars
- Seeing how multimodal real-world data and AI can be applied to narrow genome-wide candidates to a ranked target list
- Learning where target expression alone has failed to predict which organoids would respond to an ADC
- Examining how a finding from an organoid screening was tested back against real-world patient outcomes
